Webber K - Search Results

1

Imaging and phase I study of 111In- and 90Y-labeled anti-LewisY monoclonal antibody B3.

Pai-Scherf LH, Carrasquillo JA, Paik C, Gansow O, Whatley M, Pearson D, Webber K, Hamilton M, Allegra C, Brechbiel M, Willingham MC, Pastan I. Pai-Scherf LH, et al. Among authors: webber k. Clin Cancer Res. 2000 May;6(5):1720-30. Clin Cancer Res. 2000. PMID: 10815890 Clinical Trial.

2

Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts.

Choi CW, Lang L, Lee JT, Webber KO, Yoo TM, Chang HK, Le N, Jagoda E, Paik CH, Pastan I, et al. Choi CW, et al. Among authors: webber ko. Cancer Res. 1995 Nov 15;55(22):5323-9. Cancer Res. 1995. PMID: 7585595

3

Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: comparison with its single-chain analog.

Webber KO, Reiter Y, Brinkmann U, Kreitman R, Pastan I. Webber KO, et al. Mol Immunol. 1995 Mar;32(4):249-58. doi: 10.1016/0161-5890(94)00150-y. Mol Immunol. 1995. PMID: 7723770

4

Rapid and specific uptake of anti-Tac disulfide-stabilized Fv by interleukin-2 receptor-bearing tumors.

Webber KO, Kreitman RJ, Pastan I. Webber KO, et al. Cancer Res. 1995 Jan 15;55(2):318-23. Cancer Res. 1995. PMID: 7812965

5

Mutations of two lysine residues in the CDR loops of a recombinant immunotoxin that reduce its sensitivity to chemical derivatization.

Benhar I, Brinkmann U, Webber KO, Pastan I. Benhar I, et al. Among authors: webber ko. Bioconjug Chem. 1994 Jul-Aug;5(4):321-6. doi: 10.1021/bc00028a007. Bioconjug Chem. 1994. PMID: 7948099

6

B3(Fab)-PE38M: a recombinant immunotoxin in which a mutant form of Pseudomonas exotoxin is fused to the Fab fragment of monoclonal antibody B3.

Choe M, Webber KO, Pastan I. Choe M, et al. Among authors: webber ko. Cancer Res. 1994 Jul 1;54(13):3460-7. Cancer Res. 1994. PMID: 8012967

7

Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv.

Reiter Y, Brinkmann U, Webber KO, Jung SH, Lee B, Pastan I. Reiter Y, et al. Among authors: webber ko. Protein Eng. 1994 May;7(5):697-704. doi: 10.1093/protein/7.5.697. Protein Eng. 1994. PMID: 8073039

8

L-lysine effectively blocks renal uptake of 125I- or 99mTc-labeled anti-Tac disulfide-stabilized Fv fragment.

Kobayashi H, Yoo TM, Kim IS, Kim MK, Le N, Webber KO, Pastan I, Paik CH, Eckelman WC, Carrasquillo JA. Kobayashi H, et al. Among authors: webber ko. Cancer Res. 1996 Aug 15;56(16):3788-95. Cancer Res. 1996. PMID: 8706025

9

Technetium-99m labeling and biodistribution of anti-TAC disulfide-stabilized Fv fragment.

Yoo TM, Chang HK, Choi CW, Webber KO, Le N, Kim IS, Eckelman WC, Pastan I, Carrasquillo JA, Paik CH. Yoo TM, et al. Among authors: webber ko. J Nucl Med. 1997 Feb;38(2):294-300. J Nucl Med. 1997. PMID: 9025758 Free article.

10

Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.

Kobayashi H, Yoo TM, Drumm D, Kim MK, Sun BF, Le N, Webber KO, Pastan I, Waldmann TA, Paik CH, Carrasquillo JA. Kobayashi H, et al. Among authors: webber ko. Cancer Res. 1997 May 15;57(10):1955-61. Cancer Res. 1997. PMID: 9157991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters